Ken Saijo

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 4

Top Topics

Prostate Cancer

Histone Deacetylase

Top Venues

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Hiroo Imai, Ken Saijo, Sonoko Chikamatsu, Yoshifumi Kawamura, Chikashi Ishioka
LPIN1 downregulation enhances anticancer activity of the novel HDAC/PI3K dual inhibitor FK-A11. Cancer science 112 (2) (2021)
Yoshifumi Kawamura, Ken Saijo, Hiroo Imai, Chikashi Ishioka
Inhibition of IRAK1/4 enhances the antitumor effect of lenvatinib in anaplastic thyroid cancer cells. Cancer science 112 (11) (2021)
Sonoko Chikamatsu, Ken Saijo, Hiroo Imai, Koichi Narita, Yoshifumi Kawamura, Tadashi Katoh, Chikashi Ishioka
In Vitro and in Vivo antitumor activity and the mechanism of siphonodictyal B in human colon cancer cells. Cancer medicine 8 (12) (2019)
Ken Saijo, Hiroo Imai, Sonoko Chikamatsu, Koichi Narita, Tadashi Katoh, Chikashi Ishioka
Antitumor activity and pharmacologic characterization of the depsipeptide analog as a novel histone deacetylase/ phosphatidylinositol 3-kinase dual inhibitor. Cancer science 108 (7) (2017)